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1 Oleoylethanolamide (OEA) is a well-recognized anorectic compound (1). Recent investigations 
 
2 pointed out that, when administrated at a dose of 10mg/kg, it affects food reward by influencing the 
 
3 acetylcholine (ACh)/dopamine (DA) balance in the cholinergic system (1). Recent published data 
 
4 support the effect of OEA on both the homeostatic and non-homeostatic regulation of food intake 
 
5 through the activation of proliferator-activated receptor-α (PPAR-α)  in the small intestine, which 
 
6 mediates satiety signals to the brain via the afferent vagal fibers (2). 
 
7 Mammals have the enzymes to synthetize and degrade N-acetylethanolamines (NAEs),  including 
 
8 OEA.  NAEs   are   bios ynthesiz ed   “on -demand”   from   their   pr ecu rsors   N -acylated  
ethanolamine 
 
9 phospholipids, through three different enzymatic pathways (3). The absolute concentration of NAEs 
 
10 in tissues is very low, in the order of a few nmol/g of tissue, the highest concentration being present 
 
11 in the brain and intestine (3).  
 
12 NAEs, including OEA, can also be provided by certain foods, oatmeal, nuts, and cocoa  powder 
 
13 being the major food sources, but the amount per gram of OEA found in these foods is very low (<2 
 
14  μ g/g)   (4)  compared  to  the  amount  used  in  clinical  trials.  OEA can  also  be  synthetized  
upon 
 
15 ingestion of precursor-containing foods, such  as  olive oil. For example, the  intake of a  meal 
 
16 containing a high amount of oleic acid increased plasma concentration of OEA in rats and humans 
 
17 (5, 6) reducing the following energy intakes in  humans (6, for a summary of human  studies 
 
18 addressing the role of OEA on eating behavior see supplemental table1). 
 
19 NAEs hydrolysis is catalyzed by the fatty acid amide hydrolase that has a strong activity in the 
 
20 intestine, liver, brain, and at the blood-brain barrier level (7), resulting in the production of  fatty 
 
21 acids and ethanolamine (EA). After OEA is orally or intragastrically administrated in  relatively 
 
22 abundant doses, i.e. 10mg/kg, it is likely that following its degradation, a peak in oleate and EA, 
 
23 occurs  in  several  organs.  The effect  of  oleic  acid  on  the  gut-brain-axis  has  been  extensively 
 
24 investigated, whereas EA received scarce attention. One study (8) tested the effect of  oral EA 
 
25 (1.88mg/kg, the equivalent amount released by 10mg/kg of OEA) and found no effect on  food 
 
26 intake compared to a control group, in rats. However, in this study only food intake and no  other 
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27 aspects of eating behavior, such as food preferences for high sugar/fat foods that may  also be 
 
28 influenced by the  activation of brain areas  related to food  reward,  were investigated.  On the 
 
29 contrary, there are scattered evidences from old and new recent researches, which  underline the 
 
30 influence of EA on the cholinergic system. 
 
31 Here, we briefly describe OEA and EA effects on the cholinergic system, suggesting  that EA 
 
32 contributes to the overall balance between DA and ACh after OEA administration (9, 10). 
33 
34 The cholinergic system regulates food reward by interacting with the dopaminergic system 
 
35 The cholinergic system modulates various brain functions through the release of the Ach (11). This 
 
36 occurs as a result of depolarization of the axonal termination that induces 
 
37 a rise in the cytosolic Ca 2+ concentration and the fusion between the axoplasmic membrane and the 
vesicles containing ACh. 
 
38 Projection neurons constitute the main brain structure of the cholinergic system that  originates 
 
39 mainly in subcortical regions, such as the basal forebrain, and extends into many brain  regions, 
 
40 including cortical areas and the hippocampus. Interneurons with cholinergic activity were  also 
 
41 identified in specific target areas of mesolimbic system, such as the nucleus accumbens (NAc) (11), 
 
42 which are involved in pleasure and motivation, contributing to the hedonic dimension of eating. 
 
43 In the regulation of eating behavior, the cholinergic system constantly interacts with, and regulates 
 
44 the activity of one of the main neurotransmitters involved in reward, DA (12). DA is synthesized by 
 
45 dopaminergic  neurons  in  the  midbrain  (i.e.  ventral  tegmental  area  and  substantia  nigra).  The 
 
46 dopaminergic  mesolimbic  pathway is  a  neuronal  circuit  that  is  activated  in  order  to  translate 
 
47 motivation into action in a variety of behaviors, including eating (12). 
 
48 In human lean subjects, food cues stimulate DA release in the dorsal striatum (12) and  during 
 
49 eating, DA response is positively correlated with the pleasantness of the food. These  evidences 
 
50 indicate that, in lean subjects, DA may be considered as a biomarker of the hedonic value of foods. 
 
51 Conversely, in obese subjects, responses to food cues and food ingestion stimuli are blunted  (12). 
 
52 The  dopaminergic  and  the  cholinergic  systems  have  a  similar  anatomical  connectivity  with 
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53 numerous functional neuronal endings, such as in the NAc. Here, cholinergic interneurons, together 
 
54 with  dopaminergic  projections  of the  ventral tegmental area,  modulate the  activity of  gamma 
 
55 aminobutyric acid (GABA) projections neurons (12). In the NAc, ACh/DA fluctuations modulate 
 
56 eating behavior. For example, when rats are exposed to an adverse conditioned stimulus, there is a 
 
57 concomitant ACh increase and DA decrease. In addition, fasted mice in a free feeding state  stop 
 
58 eating when the ACh/DA ratio begins to increase (12). 
59 
60 OEA influences cholinergic-mediated food-reward regulation 
 
61 Some investigations also suggested that OEA influences the food-reward system by modulating DA 
 
62 release. High-fat-diet chronic consumption in mice produces a significant reduction in intestinal 
 
63 OEA synthesis, but not in other tissues, which is concomitant with a reduction of DA in the brain. In 
 
64 high-fat-diet-fed  mice,  infusion  of  OEA  (10mg/kg)  solution  25  min  before  intragastric  lipid 
 
65 emulsion infusion restored DA release. No difference was found in DA increase in response to the 
 
66 calories content of the emulsion. In low-fat-diet-fed mice, OEA influenced the release of DA when 
 
67 stimulated by intragastric infusion of a low-calorie emulsion. In addition, in low-fat-diet-fed mice, 
 
68 the infusion of OEA decreased the intake of both low-calorie and high-calorie emulsions. Finally, 
 
69 the  authors  demonstrated  that  these  effects  were  abolished  in  sub-diaphragmatic  bilaterally 
 
70 vagotomised and in PPAR-α knockout mice (1). These evidences indicate that OEA interacts with 
 
71 the mesolimbic system, probably via activation of the PPAR-α on vagal afferent nerves. In contrast, 
 
72 another  investigation  provides  evidences  that  OEA  can  regulate  DA  release  through  central 
 
73 mechanisms as well. In rats, when injected in the lateral hypothalamus, OEA increased extracellular 
 
74 DA levels in NAc (9). The molecular mechanisms of OEA–DA interaction have not been fully 
 
75 clarified yet. 
 
76 
 
77 Ethanolamine, a downstream metabolite of OEA, may serve as neuromodulator stimulating 
 
78 acetylcholine release in the brain 
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79 The quantitative degradation of 10mg of OEA may produce 1.88mg of EA and this is particularly 
 
80 interesting because it is a small molecule with a rather good ability to pass the blood-brain barrier 
 
81 and influence the activity of diverse brain areas (13). Several pioneering studies demonstrated that 
 
82 EA can be released from different brain regions following electrical or chemical depolarization (14). 
 
83 A more recent in vitro study demonstrated that, when synaptosomes and synaptoneurosomes were 
 
84 incubated  with  EA,  this  was  stored  in  intracellular  compartments,  and  released  by  classical 
 
85 exocytosis following depolarization (15). The authors pointed out that the concentration of EA 
 
86 released was low compared to a classical neurotransmitter, but they did not exclude the possibility 
 
87 that a discrete receptor exists post-synaptically for EA (15). Although EA cannot be considered as a 
 
88 pure neurotransmitter, all  in  all, these studies support  the role of EA as a neuromodulator,  a 
 
89 molecule that is not directly excitatory or inhibitory, but that can sustain both activities depending 
 
90 on the site and the time frame of its release. Therefore, it is convincing that the EA released from 
 
91 the degradation of NAEs in the intestine or at the blood-brain barrier level may play a role in the 
 
92 brain. In fact, it is known that EA can modulate neurotransmitters. It was shown that EA stimulates 
 
93 the release of aspartic and glutamic acids in the anterior hippocampus of rabbits (16), and it is also 
 
94 known to inhibit the enzyme GABA aminotransferase with the consequence of reducing GABA 
 
95 breakdown and increasing its concentration in the brain (17). 
 
96 Some  investigations  demonstrated  that,  similarly to  OEA,  EA could  influence  the  cholinergic 
 
97 system. A first suggestion came from the neuronal cells’ ability to use EA as a precursor of ACh. In 
 
98 chicken neuronal cultures, it was proved that EA is rapidly phosphorylated to phosphoethanolamine 
 
99 and converted to phosphatidylethanolamine that may also be methylated to phosphocholine (18). In 
 
100 vivo, intraventricular injections of 3H-EA showed that the rat brain has the capacity to synthetize 
 
101 free choline de novo by stepwise methylation of EA, phosphoethanolamine and 
 
102 phosphatidylethanolamine (19). In the human cell line neuroblastoma LA-N-2, it was demonstrated 
 
103 that the same pathway exists and that the choline thus produced is a source of de novo synthesis of 
 
104 ACh (20). In contrast, Ansell and Spanner (21) described that after injection of labeled EA in the 
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105 ventricle  side  of  the  rat  brain,  labeled  phosphatidylethanolamine  was  formed,  but  no  labeled 
 
106 phosphatidylcholine was found. Similar results were obtained by Browning and Schulman (22) in 
 
107 slices of cerebral cortex of rats. They showed that labeled ACh was formed in the presence of 
 
108 labeled choline, whereas ACh was not labeled if choline was substituted with labeled EA, serine or 
 
109 methionine. Therefore it is accepted that, although the conversion of EA in ACh is possible, in vivo 
 
110 and in the presence of normal plasma choline levels, EA is not used for choline and ACh synthesis. 
 
111 However, other investigations found that EA can increase ACh extracellular concentration in the 
 
112 brain by indirect mechanisms. In cultured explants of the medial septal nucleus from rat brains, EA 
 
113 enhances the ability to develop cholinergic neurons to utilize choline for the production of ACh 
 
114 (23). EA has been shown to increase extracellular levels of ACh in rat hippocampus slices during 
 
115 continuous infusion in a depolarizing KCl buffer. This increase was not mediated by a greater 
 
116 synthesis of ACh, but by a higher cellular release that would be stimulated by amino-alcohols such 
 
117 as EA (24). In a subsequent study, they suggested that the mechanism through which amino- 
 
118 alcohols facilitate ACh release in the hippocampus may involve the activation of calcium channels 
 
119 (25).  Interestingly,  this  effect  appears  to  be  specific  to  cholinergic  endings,  since  other 
 
120 neurotransmitters, such as norepinephrine and DA, were not affected. A similar result was obtained 
 
121 by Khairy et al. (10) who have shown that the application of EA on dorsal root ganglion (DRG) 
 
122 neurons cells, with a threshold of 10 nM, increases the amplitude and duration of the transport of 
 
123 KCl-stimulated Ca2+ release. Furthermore, EA stimulated voltage-activated K+ currents 
 
124 independently of the activation of Ca2+  channels. In another study, Liao et al. (17) in accordance 
 
125 Bostwick, also found that EA increased neurotransmitters release from brain synaptosomes, but they 
 
126 proposed different mechanisms of release. They demonstrated that synaptosomes incubated with 
 
127 EA, at a concentration from 0.31mM to 5mM, increased their capability to release 
 
128 neurotransmitters,  i.e.  [3H]-D-aspartic  acid.  They  suggested  that  EA  permeated  into  synaptic 
 
129 vesicles and increasing their filling capability. The enhanced capability of synaptic vesicles to load 
 
130 neurotransmitters explains how EA   influence may regulate synaptic transmission. The 
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131 concentrations used in the study were within physiological levels of EA in the brain, i.e. between 
 
132 197–870 nmol/g (17). 
 
133 Therefore, even if the mechanisms are still not clear, there are strong evidences to support that EA 
 
134 influences neurotransmitters release in the brain. This is of great interest especially when the source 
 
135 of EA is OEA, because this NAE has itself an action on the cholinergic/dopaminergic system. It is 
 
136 also possible that there are differences in the overall effect on the brain between the administration 
 
137 of pure EA, as investigated by Nielsen et al (8) and EA released following OEA degradation, since 
 
138 this EA can keep acting on neurotransmitters previously stimulated by OEA. 
 
139 In conclusion, these evidences support the hypothesis that OEA and its metabolite, EA, can interact 
 
140 in the regulation of the overall ACh/DA balance influencing brain areas involved in food-reward 
 
141 (Figure 1). Taking into account this perspective, further studies should investigate the kinetic of EA 
 
142 release following OEA administration and whether it can impact the cholinergic regulation of 
 
143 
 
144 
dopamine. 
 
145 Statement of  authors’ contributions  to manuscript:  IM,  GB  and DV wrote  the article,  IM 
 
146 designed research and had primary responsibility for final content. All authors have read and 
 
147 approved the final manuscript. 
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Figure Legends 
 
Figure 1. Schematic representation of oleoylethanolamide (OEA) and ethanolamine (EA) effects on 
acetylcholine/dopamine (ACh/DA) balance. From intestine, OEA communicates via vagal afferent fiber with 
brain areas regulating DA release. OEA is then degraded by the enzyme fatty acid amide hydrolase in oleic  
acid and EA, which pass into the bloodstream and can in part penetrate the blood brain barrier. In the brain, EA 
acts as a neuromodulator being able to stimulate cholinergic neurons ACh release. ACh/DA fluctuations 
modulate eating behavior. 
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